Gene · 6439
NIH grants2,156
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 2,156
Download this page as JSON| Grant | Title | SFTPB papers | Newest fiscal year |
|---|---|---|---|
| R01HL157985 | VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19 | 1 | 2025 |
| R01HL158096 | IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients | 1 | 2025 |
| R01HL158139 | Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19 | 1 | 2025 |
| R01HL161829 | Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes | 1 | 2025 |
| R01HL164414 | Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation | 1 | 2025 |
| R01HL165265 | Role of Complement Activation in Severe COVID-19 | 1 | 2025 |
| R01HL166139 | Functional interrogation of a novel SCGB3A2+/SFTPB+ cell in the human airway | 1 | 2025 |
| R25ES020721 | Summer Research Experience Programs (R25) | 1 | 2025 |
| R25ES025476 | Colorado Undergraduate Research in Environmental Health Sciences | 1 | 2025 |
| R35CA197449 | Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research | 1 | 2025 |
| R35GM118109 | Mechanisms linking replication stress to genome instability in fission yeast | 1 | 2025 |
| R35GM126900 | Mechanisms of chromatin and transcriptional regulation | 1 | 2025 |
| R35GM127029 | DNA damage response and repair of a broken chromosome | 1 | 2025 |
| R35GM131707 | Control of cell proliferation and differentiation by growth pathways | 1 | 2025 |
| R35GM134920 | Molecular Basis of Centromere Specification and Inheritance | 1 | 2025 |
| R35GM142695 | Statistical and Machine Learning Methods to Address Biomedical Challenges for Integrating Multi-view Data | 1 | 2025 |
| R35HL150754 | Identifying new strategies for prevention of cardiovascular complications of diabetes | 1 | 2025 |
| R35HL150767 | Program to promote lung regeneration and block fibrosis | 1 | 2025 |
| R37GM065859 | Intra- and Inter- Species Communication in Bacteria | 1 | 2025 |
| R50CA211199 | Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6439/grants?page=12